The pandemic has had a far-reaching impact across many business sectors. For pharma, it has meant reassessing and adapting various aspects of operations including supply chains, launch strategies and engagement with customers and regulatory agencies.
Six Questions For Sun Pharma MD Shanghvi
Sun Pharma’s founder and MD shares with Scrip his views on some key big picture issues, including leveraging pandemic-related regulatory experience for urgently needed products, expectations in the US market, the outlook for M&A, and the potential of e-pharmacies in India.
